Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy
Clinical trial NCT04928365 · UNKNOWN
Trial details
- NCT number
- NCT04928365
- Sponsor
- Blokhin's Russian Cancer Research Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2021-05-11
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.